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IntroductIon
Inflammation of the appendix is the most common 
surgical disease in childhood1. Appendicitis rarely oc-
curs in the neonatal period and infancy and it is often 
diagnosed with delay2. In the USA 80000 children un-
dergo appendectomy per year and one third of them 
present to the hospital with perforation of the inflamed 
appendix, thus increasing the possibility of develop-
ing complications in 58% of cases3. 
Ascending septic pylephlebitis with septic clots in 
the portal vein, stem or branch, such as the superior 
mesenteric vein, occurs in 0.05% of cases with acute 
appendicitis and 3% of cases with peritonitis due to 
rupture of the inflamed appendix4. The first descrip-
tion of a liver abscess development caused by inflam-
mation of the appendix followed by septic pylephle-
bitis was made in 1898 by Dieulafoy5 and the first 
published study was by Ochner in 19386. 
This case report refers to an 11 months old female 
infant who presented with acute abdomen due to ap-
pendicitis and was later on diagnosed with ascending 
septic pylephlebitis. She developed 2 abscesses in the 
right lobe of the liver. Based on current literature this 
complication in correlation with the young age of our 
patient appears to be very rare. 
cASE rEPort
An 11 months-old female infant was admitted to our 
department with acute abdomen. She had a disease 
free personal history and her pre- and postnatal peri-
ods were uneventful. The onset of the disease was a 
week prior to admission with fever, abdominal pain, 
anorexia, drowsiness and diarrhea. After fluid resusci-
tation an abdominal ultrasound was performed which 
revealed the presence of a rigid tubular lesion near 
the right iliac fossa and enlarged mesenteric lymph 
nodes. Also a small amount of fluid was present 
(Figure 1). At laparotomy we found: a) the appen-
dix with evidence of inflammation, b) periapendiceal 
slobbery exudate (sent for cultivation) and c) iso-
lated, enlarged mesenteric lymph nodes. (Figures 2, 
3). Appendectomy was performed and a nasogastric 
tube into the stomach was inserted. The cultivation of 
peritoneal fluid revealed E.coli. She was administered 
cefuroxime 50 mg/KWB in 2 doses daily, amikacin 15 
mg/ KWB in 2 doses daily and metronidazole 24mg/
KWB in 3 doses daily. The patient was febrile dur-
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ing the first two postoperative days (up to 38.5° C) 
and had abdominal distention and sparse intestinal 
sounds. On the second postoperative day white blood 
cell count was 4000/ml with a lymphocyte type, he-
matocrit was 24.8% (transfusion of 150 ml of blood 
was performed) and platelet count was 78000/ml. 
Liver enzymes were affected and CRP remained el-
evated (24 mg/dl vs 30 mg/dl preoperatively). During 
the third postoperative day a small abscess in the right 
lobe of the liver was detected by ultrasonography. 
Abdominal CT scan revealed 2 abscesses in the right 
lobe of the liver, the largest of maximum diameter 1.7 
cm and the presence of septic thrombus in the stem of 
Figure 1. Ultrasound imaging of the rigid 
tubular lesion corresponding to the appendix.
Figure 2. Inflamed appendix at laparotomy.
Figure 3. Histopathologic image of appendicitis.
Figure 4. Ultrasound imaging of the largest liver abscess, 
1,7 cm in diameter. 
Figure 5. CT scan of the abdomen: a) two liver abscesses 
and b) septic thrombus into the stem of the portal vein. 
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the portal vein, without obstruction of the blood flow 
(Figures 4, 5). The cefuroxime dosage was increased 
and meropenem (100 mg / KWB / in 3 doses daily) 
was added. The young patient started to show clinical 
improvement on the 5th postoperative day and on the 
8th postoperative day body temperature was normal. 
Laboratory results are shown on Table 1. 
The abdominal ultrasound was repeated: a) on the 
6th postoperative day: there was no thrombus in the 
stem or the branches of the portal vein and the largest 
liver abscess was 1.2 cm in diameter b) on the 12th 
postoperative day: no altered findings and c) on the 
18th postoperative day: the largest abscess showed 
regression (diameter was 7.5 mm). After a follow up 
period of 3 months portal hypertension has not de-
veloped. In addition, the infant underwent tests for 
excluding underlying immune system indeficiency 
including: 
• Measurement of serum immunoglobulins.
• Definition of immunophenotype of T / B lym-
phocytes and phagocytes.
• Definition of serum C1, C2, C3 and C4 levels. 
Except for a slight increase in IgG count, all results 
were within normal limits. The presence of neutrope-
nia led to further investigation of the phagocytic func-
tion as judged by the MFI index and DHR assay by 
flow cytometry: the results were also within normal 
limits. 
table 1. Blood test results during post-operative follow-up.
POD**
OP *** 1st 2nd 3rd 4th 5th 8th 17th
BTR *
WBC μL 21000 11100 4700 3800 4000 2700 7400 7900
NE % 85.8 66.4 47.7 51.9 15 11 19 24
LY % 8.7 8.7 38.4 29.9 54 85 73 62.1
HCT % 31.4 28.3 23 34.4 34.3 32.7 33.8 32
Hb g/dl 10.5 9.3 8 11.4 11.4 11.3 11.2 10.6
PLT μL 223000 174000 78000 220000 339000 250000 665000 458000
SGOT U/L 71 121 128 62 57 63 44 72
SGPT U/L 32 92 100 62 44 37 32 31
CRP mg/dl 30 25 24.4 15.5 12.3 11 7 0.7
PT sec 12.6
Aptt sec 38.2
Fib g/L 4.6
Tot bil mg/dl 0.7 0.68 0.71
     *  BTR: Blood Test Results 
  **  PO: Post-Operative Days 
***  OP: Operation Day (pre-operative blood test results)
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dIScuSSIon 
Septic ascending pylephlebitis may develop after 
pancreatitis, cholecystitis, inflammatory bowel dis-
ease or other intra-abdominal inflammation, such as 
appendicitis7. A serious infection of an organ which 
has venous drainage to the portal vein or is in close 
anatomic relation to the portal vein can be compli-
cated by ascending pylephlebitis7,8. The incidence of 
liver abscesses developing after ascending pylephle-
bitis due to intraabdominal sepsis is 3-25/100.000 ad-
missions of pediatric patients9. This is a very serious 
complication, even today, with mortality rates extend-
ing to 32%10. Less than 10% of all liver abscesses are 
secondary to appendicitis7. Muorah M and colleagues 
(2006) describe the treatment of 15 patients with liver 
abscesses due to intraabdominal infection12. In this 
study one 13-year old patient presented with ruptured 
appendicitis. After literature review, we found no ref-
erences of patients with liver abscesses due to appen-
dicitis and ascending septic pylephlebitis, aged less 
than or equal to 11 months 
The most common organisms that are responsible 
for liver abscess secondary to appendicitis are E.coli 
(as in our case), Bacteroides fragilis, Proteus mirabi-
lis, Klebsiella pneumoniae, Enterobacter strains and 
various streptococci7,9. 
Disorders of the innate immunity, particularly neu-
trophil disorders, should be excluded in all cases, even 
when there is no suggestive history. Our patient was 
tested for the possibility of predisposing immune de-
ficiency11] and all results were within normal limits.
The clinical findings of this complication are not 
specific and diagnosis often delayed7. The most com-
monly reported symptoms are fever, nausea, diarrhea 
and abdominal pain located in the upper abdomen and 
the right costal margin13. Findings also include promi-
nent jaundice, sensitivity to palpation of the liver, 
hepatomegaly and splenomegaly7. In our case there 
were no clinical signs of improvement after opera-
tion, fever insisted, abdominal flatulence was present, 
restlessness and diarrhea continued. The patient never 
developed jaundice. 
High-resolution computed tomography is consid-
ered to be the most appropriate method for the diag-
nosis of septic ascending pylephlebitis7,12,13. Monitor-
ing the evolution of the septic thrombus and 2 liver 
abscesses was possible with the use of ultrasound and 
Doppler ultrasonography. On the fifth postoperative 
day the ultrasound scan showed no septic clot within 
the portal vein and the abscesses where diminishing- 
the largest one had a diameter of 1,2 cm (compared to 
1,7 cm in the first scan). 
As part of the therapeutic strategy, since the sep-
tic cause had already been removed, we insisted on 
intravenous administration of broad spectrum anti-
biotics (meropenem, amikacin and metronidazole). 
The infant had rapid clinical response: the body tem-
perature was normal on the seventh postoperative day 
and CRP levels decreased gradually. After 2 weeks of 
intravenous administration, the antimicrobial therapy 
was continued by oral administration of second gen-
eration cephalosporin for 6 weeks . The requisite time, 
estimated through similar-based studies but mainly 
empirically, ranges from 3-4 to 6-8 weeks9,13. The nor-
malization of CRP is a criterion that could be used 
for evaluating the duration period of administrating 
peros antibiotic therapy9,12. In our case, CRP was nor-
malized by the 17thpostoperative day. Image guided 
(by CT or US) percutaneous drainage of the abscesses 
was not required, because of their small diameter. 
Based on current literature this approach is indicated 
when -despite antimicrobial therapy- the septic condi-
tion remains and liver abscesses have large diameters 
(3, 5-4 cm) without showing decrease in their size9,13. 
Antithrombotic therapy was not used, because of lim-
ited experience of anticoagulants in this age group and 
early imaging disappearance of the thrombus (on the 
6th postoperative day, 3 days after diagnosis of py-
lephlebitis). Anticoagulant therapy is recommended 
in cases of persisting sepsis despite administration of 
antimicrobial therapy and when a septic thrombus ex-
tending to the branches of the portal vein is present7, 
12,14. Intestinal ischemia and necrosis due to extension 
of the septic thrombus into the superior mesenteric 
vein reaches up to 5% of cases7. Removal of the septic 
clot using a Fogarty catheter inserted through the ileo-
colic vein has been described8. There is no experience 
in this therapeutic approach in infants.
Portal hypertension may develop 2-9 months af-
ter the development of pylephlebitis (average period 
3 months) therefore our patient is still monitored for 
this potential complication12. 
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In conclusion, ascending pylephlebitis with liver 
abscess development after appendicitis is a rare disor-
der in childhood and infancy but should be suspected 
and diagnosed promptly using appropriate investiga-
tion. Therapeutic approach varies but there is little 
experience in this age group. Awareness of portal ve-
nous thrombosis and portal hypertension development 
is essential.
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ΠΕΡΙΛΗΨΗ: Η ανάπτυξη ανιούσας σηπτικής πυλαιοφλεβίτιδας απότοκος γαγγραινώδους σκωληκοειδίτιδας με συνέπεια 
την ανάπτυξη ηπατικών αποστημάτων, αποτελεί σπανιότατη επιπλοκή ιδιαίτερα στη βρεφική ηλικία. Στην παρούσα μελέτη 
αναφερόμαστε σε βρέφος 11 μηνών με τη παραπάνω κλινική σημειολογία που αντιμετωπίσθηκε επιτυχώς στη κλινική μας. 
Με αφορμή αυτή τη σπανιότατη οντότητα επιχειρήσαμε αναδρομή στην πρόσφατη βιβλιογραφία, στοχεύοντας στην κωδι-
κοποίηση των κλινικών και προγνωστικών παραμέτρων.
Λέξεις Κλειδιά: Γαγγραινώδης σκωληκοειδίτιδα, Ανιούσα σηπτική πυλαιοφλεβίτιδα, Ηπατικό απόστημα.
Ανιούσα σηπτική πυλαιοφλεβίτιδα με ανάπτυξη ηπατικών αποστημάτων  
λόγω γαγγραινώδους σκωληκοειδίτιδας σε κορίτσι 11 μηνών  
(παρουσίαση περιστατικού).
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